Among patients with multiple myeloma (MM) undergoing autologous stem cell transplantation (ASCT), atrial fibrillation (AF) is a frequent and high-risk complication, according to a study published online Feb. 17 in JACC: CardioOncology.
This article was originally published on MedicalXpress.com

